(Q53729853)

18 May 2018

title

L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease. (English)

1 reference

18 May 2018

(S)-(−)-carbidopa monohydrate

1 reference

1 reference

1 reference

Glasgow GL

1

1 reference

18 May 2018

Henley JW

series ordinal

2

1 reference

18 May 2018

Willoughby EW

series ordinal

3

1 reference

18 May 2018

publication date

1 August 1974

1 reference

18 May 2018

Australian and New Zealand journal of medicine

published in

1 reference

18 May 2018

volume

4

1 reference

18 May 2018

issue

4

1 reference

18 May 2018

page(s)

373-378

1 reference

18 May 2018

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03207.X

Prevention or reversal of levodopa-induced cardiac arrhythmias by decarboxylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03207.X

Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03207.X

Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03207.X

Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03207.X

Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03207.X

10.1111/J.1445-5994.1974.TB03207.X

21 January 2018

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018